Avadel Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVDL and other ETFs, options, and stocks.

About AVDL

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy.

CEO

Gregory J. Divis

CEOGregory J. Divis

Employees

188

Employees188

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2015

Founded2015

Employees

188

Employees188

AVDL Key Statistics

Market cap

1.05B

Market cap1.05B

Price-Earnings ratio

-39.52

Price-Earnings ratio-39.52

Dividend yield

—

Dividend yield—

Average volume

1.07M

Average volume1.07M

High today

$11.09

High today$11.09

Low today

$10.70

Low today$10.70

Open price

$11.01

Open price$11.01

Volume

1.23M

Volume1.23M

52 Week high

$17.30

52 Week high$17.30

52 Week low

$6.38

52 Week low$6.38

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own AVDL. This list is generated using Robinhood data, and it’s not a recommendation.

Avadel Pharmaceuticals

Why Robinhood?

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. Show more

AVDL Key Statistics

Analyst ratings

100%

People also own

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy.